Use of non-invasive cardiac monitoring to guide discontinuation of postpartum magnesium sulfate in individuals with preeclampsia with severe features.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

To determine the utility of using total peripheral systemic vascular resistance assessed using non-invasive cardiac monitor for individualizing the duration of postpartum magnesium sulfate in individuals with preeclampsia with severe features.

Who Took Part

By PubMed's age tags, the people studied were adults, women only.

How the Study Was Run

The researchers set it up as a randomized and pilot study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

Systemic vascular resistance was assessed with non-invasive cardiac monitoring using the Cheetah® system.

Their primary outcome was duration of postpartum magnesium sulfate use in hours.

What Was Measured

Topics PubMed links to this paper include Magnesium Sulfate, Pre-Eclampsia, Postpartum Period, Vascular Resistance, Pilot Projects and Monitoring, Physiologic.

The authors tagged it with the keywords Non-invasive cardiac monitoring, Preeclampsia and Systemic vascular resistance.

What This Means in Plain Language

The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (Pregnancy hypertension), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.